Regeneron
Trade Regeneron 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About REGN
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara.
REGN Key Statistics
Stock Snapshot
With a market cap of 78.08B, Regeneron(REGN) trades at $738.69. The stock has a price-to-earnings ratio of 17.78 and currently yields dividends of 48.5%.
On 2026-03-20, Regeneron(REGN) stock traded between a low of $734.88 and a high of $744.85. Shares are currently priced at $738.69, which is +0.5% above the low and -0.8% below the high.
The Regeneron(REGN)'s current trading volume is 195.65K, compared to an average daily volume of 534.05K.
During the past year, Regeneron(REGN) stock moved between $476.49 at its lowest and $821.11 at its peak.
During the past year, Regeneron(REGN) stock moved between $476.49 at its lowest and $821.11 at its peak.
REGN News
In the latest look at the underlying components of the S&P 500 ordered by largest market capitalization, Regeneron Pharmaceuticals, Inc. (Symbol: REGN) has take...
Wells Fargo raised the firm’s price target on Regeneron to $825 from $800 and keeps an Equal Weight rating on the shares. The firm thinks new drugs and mechanis...
(RTTNews) - Formycon AG (FYB.DE, FYBGF), an independent German biotechnology company, on Thursday announced that it entered into a settlement and license agreem...
Analyst ratings
73%
of 30 ratingsMore REGN News
Regeneron Pharmaceuticals (REGN), Sanofi SA (SNY) announced an update on their ongoing clinical study. The study “A Double-blinded Extension Study to Evaluate...
Advertisement Regeneron Pharmaceuticals stock: context behind recent moves Regeneron Pharmaceuticals (REGN) shares have seen mixed returns recently, with a 1...
Over the past two years, Eli Lilly (LLY +0.80%) has established itself as the leader in the weight loss market. That's thanks to the company's tirzepatide, a co...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.